Cushing's Syndrome Clinical Trials Cushing's Syndrome RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor
Conditions:   Autonomous Cortisol Secretion (ACS);   ACTH-Independent Cushing Syndrome;   ACTH-Independent Adrenal Cushing Syndrome, Somatic Interventions:   Drug: SPI-62 dose1;   Drug: SPI-62 dose 2;   Drug: SPI-62 dose 3;   Drug: SPI-62 dose 4;   Drug: Placebo Sponsor:   Sparrow Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2022 Category: Research Source Type: clinical trials